Technologies
FDA, Pfizer delay authorization for COVID vaccine for kids under 5: What to know
The FDA will review data on all three doses of the vaccine for young kids, instead of starting with just two. The data should be available in early April.

Parents of children under 5 will have to wait a little longer to get their kids vaccinated against COVID-19.
Pfizer and BioNTech announced Friday that the companies are extending their «rolling submission» process for the vaccine for kids 6 months through 4 years and are waiting for more data on all three doses before asking the US Food and Drug Administration to authorize the first two shots. Just two doses of the vaccine weren’t effective for the whole age group.
The FDA said on Friday that the agency is postponing its Feb. 15 committee meeting, which would’ve included a vote on whether to move forward with the first doses of the COVID-19 vaccine for young kids. The agency said that it will provide an updated time for a new meeting once the FDA receives additional data for the full vaccine.
«The extension allows the FDA time to receive updated data on the two- and three-dose regimen, conduct a thorough evaluation of it, and facilitate a robust, public discussion,» Pfizer and BioNTech said in the announcement. The companies expect to have three-dose protection data by early April, they said.
Last week, Pfizer and BioNTech submitted data to the FDA for authorization of their COVID-19 vaccine for children 6 months through 4 years old. While the vaccine for children under 5 is expected to be a three-dose vaccine series (it’s one-tenth the volume of Pfizer’s vaccine for people 12 and up), the FDA asked the companies to submit data on the first two doses as part of a «rolling submission» process.
In December, Pfizer announced that while two doses of the vaccine were effective in children ages 6 months to 2 years, two shots failed to promote a strong enough immune response in children ages 2 through 4 years. This prompted the company to start testing a three-dose version of the vaccine for children under 5.
Updated Sunday, the Centers for Disease Control and Prevention’s Pediatric COVID-19 Vaccination Operational Planning Guide indicates that the agency has 10 million vaccine doses ready for dispersal, and that state and local health officials could start receiving doses as early as Feb. 21. Without FDA authorization beforehand, this will be postponed.
Kids as young as 5 have been able to be vaccinated against COVID-19 since October 2021. The Kaiser Family Foundation reports that 28.1% of kids 5 to 11 have received at least one vaccine shot as of Jan. 18. Read on to learn everything you need to know about COVID-19 vaccines for kids under 5.
Also, learn about whether we’ll need a fourth booster shot, the latest on long COVID and the possibility of a vaccine that works against all COVID-19 variants.
Why did Pfizer and the FDA extend the authorization process?
At the FDA’s request, Pfizer and BioNTech started the submission process last week for authorization of the first two doses of the vaccine for kids 6 months through 4 years last week.
But in a statement Friday, the FDA said: «Based on the agency’s preliminary assessment, and to allow more time to evaluate additional data, we believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization.»
The vaccine for children under 5 covers kids 6 months through 4 years. While two shots of the smaller-dose vaccine were effective in babies and toddlers 6 months to 2 years, receiving only two doses failed to promote a strong immune response in children 2 to 4 years. Studies on a third dose are ongoing, but expected to complete the series for kids under 5.
«Given that the study is advancing at a rapid pace, the companies will wait for the three-dose data as Pfizer and BioNTech continue to believe it may provide a higher level of protection in this age group,» the companies said Friday.
The extension of the rolling submission process for the vaccine for kids under 5 comes as a disappointment for many parents wanting to protect their younger children against COVID-19, but it’s more in line with earlier estimates from public health officials on when a COVID-19 vaccine might be available for the age group.
When can babies and children under 5 get the vaccine?
Once Pfizer and BioNTech submit additional information to the FDA, a committee of experts that gathers to discuss safety and effectiveness data and vote on whether or not the FDA should authorize a vaccine will meet. The agency will provide an update on timing for the meeting on the vaccine for kids under 5 once they receive more data, FDA Commissioner Dr. Janet Woodcock and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a statement Friday.
«This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines,» the doctors said.
The advisory committee’s meetings are open to the public.
If the FDA does authorize Pfizer’s vaccine for children as young as 6 months old, the CDC typically goes through the same process: An outside panel of health experts will discuss the benefits and risks of recommending the vaccine to children under 5 years old. If they vote to recommend Pfizer’s vaccine for the younger age group, the CDC’s director will likely accept the panel’s decision and the small doses of Pfizer’s COVID-19 vaccine for kids will become available in pediatricians’ offices or other clinics.
Pfizer and BioNTech’s COVID-19 vaccine is not the only one being studied in kids under 5, however. Moderna said in January that it expects to report vaccine data on children 2 to 5 years in March. In a few countries outside the US, including Canada, Moderna’s vaccine has received regulatory authorizations for adolescents 12 and up.
How is Pfizer’s child vaccine for young kids different?
Pfizer and BioNTech’s vaccine for children 6 months through 4 years comes in two doses that are one-tenth the volume of the vaccine for people age 12 and up. A third 3-microgram dose is being researched right now is expected to complete the series.
The vaccine for kids 5 to 11 is one-third the dose given to everyone 12 and up, and it’s delivered in two doses. Pfizer’s vaccine for kids can also be stored for up to 10 weeks in a fridge, making it easier to administer, and the cap on the vial is orange instead of purple and gray to avoid mix-ups.
And if it helps to put your kids at ease, the needle used to administer the child’s dose of vaccine is also smaller.
For more information about Pfizer’s vaccine for children ages 5 to 11, check out this fact sheet from the FDA.
Can my child get a COVID booster?
Children as young as 12 can now get a booster dose of Pfizer’s COVID-19 vaccine, given at least five months after their primary vaccination series.
Most kids younger than 12 can’t get a booster, although the CDC recommends a third dose of the Pfizer vaccine for children 5 and up who are immunocompromised. They’re eligible for a third shot 28 days after their second dose.
Where can my kid get a booster shot?
Since Pfizer’s COVID-19 vaccine is the lone vaccine approved for people under 18, it’s generally only available in doctor’s offices and public health clinics, not pharmacies and other mass vaccination sites.
Call your pediatrician or local health clinic for a recommendation on where to go. Parents may also text their ZIP code to 438829 or use this vaccine finder link to find a clinic near them that has the child vaccine available.
Do kids really need a COVID-19 vaccine?
According to a report from the American Academy of Pediatrics, children made up 25% of reported COVID-19 cases for the week ending Feb. 3. (The AAP says the definition of «child» varies by the states reporting.) While pediatric cases were lower than in January, child COVID-19 were «double the peak level of the delta surge in 2021,» the AAP reported.
While it’s true children are much less likely to get severely sick from the virus than adults, some children have died or been hospitalized with the virus. An infection, even a mild case, requires quarantining and potentially sending classmates out of the classroom and back to remote learning. And kids can experience dangerous complications from COVID-19, including long COVID and MIS-C.
There are also racial disparities in the severity of how sick children get from COVID-19: Kids ages 5 to 11 who are Black, Native American or Hispanic are three times more likely to be hospitalized with COVID-19 than white children, according to an FDA advisory panel presentation. Of that group, about 1 in 3 will require admission to an intensive care unit.
Are booster shots safe for children?
In a statement following its authorization of booster doses for kids 12 to 15, the FDA said it reviewed real-world data from more than 6,300 children in Israel, ages 12 to 15, who received a booster shot at least five months after their second dose of Pfizer.
No additional safety concerns were reported to date in those individuals, according to the FDA.
«These additional data enabled the FDA to reassess the benefits and risks of the use of a booster in the younger adolescent population in the setting of the current surge in COVID-19 cases,» the agency said. «The data shows there are no new safety concerns following a booster in this population.»
What are the side effects? Is the COVID vaccine safe for kids?
Vaccine side effects in kids ages 5 to 11 are mostly mild and similar to those adults may experience, according to the CDC, including soreness at the injection site, fever, muscle soreness, nausea and fatigue. In a Dec. 13 report from the agency, the CDC reviewed reports from safety monitoring systems on more than 8 million doses of Pfizer’s vaccine given to kids ages 5 to 11, confirming that children’s immune systems respond well to the vaccine with common mild side effects, and that serious adverse events are rarely reported.
Inflammation of the heart muscle, known as myocarditis, and of the muscle’s outer lining, called pericarditis, are rare and typically mild side effects linked to the Moderna and Pfizer vaccines, mostly in adolescent males and young men ages 12 to 29. (Myocarditis can also occur after infection with COVID-19.)
In one study, the CDC said that 54 recipients out of a million males ages 12 to 17 experienced myocarditis following the second dose of Pfizer-BioNTech’s Comirnaty vaccine. In contrast, kids ages 5 to 11 who catch COVID-19 have a higher risk of multisystem inflammatory syndrome, or MIS-C, a potentially serious complication involving inflammation of the heart, lungs, kidneys, brain, skin, eyes or other organs.
«The bottom line is that getting COVID is much riskier to the heart than anything in this vaccine, no matter what age or sex you are,» Dr. Matthew Oster, a pediatric cardiologist at Children’s Healthcare of Atlanta, told the CDC in November as reported by ABC News.
Do I need to give consent for my young child to get vaccinated?
Yes, parents generally need to consent to their children receiving medical care, including Pfizer’s COVID-19 vaccine. This is especially true for younger children.
However, depending on which state you live in, there may be a legal precedent for teens and other kids to request the vaccine without parental permission: Tennessee’s vaccine director, Michelle Fiscus, was fired in August allegedly in part for sending out a memo detailing Tennessee’s «mature minor doctrine,» which explains how minors may seek medical care without the consent of their parents.
If my child has a serious health condition, can they get a third shot?
The CDC recommended a third dose for children as young as 5 who are «moderately to severely» immunocompromised, 28 days after their second shot. This guidance for immunocompromised children (including kids who’ve had an organ transplant or are taking medications that suppress the immune system) is in line with guidance for adults whose bodies don’t mount a good immune response to the COVID-19 vaccines.
My child has allergies. Can they get the vaccine?
Yes, though you might be asked to stick around the waiting room so health care providers can monitor them for (extremely rare) allergic reactions that can occur after any vaccination.
«If the child has a history of anaphylaxis or other severe allergies, then the observation time after the injection may be 30 minutes instead of 15,» said Dr. Anne Liu, an infectious disease specialist with Stanford Hospital and Clinics and the Lucile Packard Children’s Hospital. Children who have been prescribed an EpiPen for any reason should bring it to their vaccine appointment, Liu added.
As with adults, children with an allergy to an ingredient in Pfizer’s COVID-19 shouldn’t take it. You can find a list of ingredients in Pfizer’s vaccine for kids ages 5 to 11 on the FDA’s fact sheet.
Can my child get the COVID-19 shot at the same time as other vaccines?
According to the CDC, your child may get other vaccines when they go in for their COVID shot without waiting 14 days between appointments. Flu shots can be given to children ages 6 months and older.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.
Technologies
Nintendo’s Pokemon Legends: Z-A Is a Hit. Just Ask My Kid
Pokemon Legends: Z-A has sucked my family in, and I can’t get my Switch controller back from my son.

I’d love to tell you all about Pokemon Legends: Z-A, arriving this week, and what it’s been like to play on the Nintendo Switch 2. I can mostly do that — but for most of the past five days, it hasn’t really been me playing. What started as co-playing together quickly turned into my kid taking over completely as he got hooked. And honestly, I’d say that’s a good sign.
Nintendo makes a lot of Pokemon games, too many for me to keep track of. But Legends Z-A is the first that’s Switch 2-optimized, although you can play on original Switches, too. I can’t tell you what that’s like, though — my early review access limited me to playing Pokemon Legends: Z-A on the Switch 2 only at home. I was doubtful about how much a city-based game would truly feel like a must-have experience, but so far it’s already become one of my favorite Pokemon games ever.
I’ll let my son tell you. He’s gotten deep into the trading card game and has played most of the recent Pokemon titles over the past year, and he says this is his favorite so far. When I asked him why, he said it’s because the game completely rethinks how battles work. The quick, real-time system feels more immediate and far less sluggish than in past Pokemon games. Plus, he’s loving the story… and honestly, so am I.
A city full of surprises
My son loves the «peculiar» storyline, the fast-paced battles (which he now wants in every Pokemon game) and the constant sense of surprise while exploring Lumiose City.
All of Pokemon Legends: Z-A (at least from what I’ve seen in my 10-plus hours so far) takes place entirely within Lumiose City — a Paris-like metropolis where the CEO of a company called Quasartico Inc. is planning to rebuild everything into a new world where Pokemon and humans can better coexist. The setup reminded me of the Detective Pikachu movie during my demo a few weeks ago, and it turns out my instincts were right.
Pokemon roam in wild zones within the city, occasionally spilling into urban areas, while mysterious rogue «Mega Evolution» Pokemon have begun appearing and threatening the city’s calm. There’s clearly a deeper mystery at play, and while I’m still uncovering it, I won’t spoil anything here.
The game seems to mostly involve a journey to level up in rank from Z to A by battling various Pokemon trainers, but that’s not the whole story. There’s a group of friends you hang out with at a local hotel, along with research missions you have to carry out. Side quests are everywhere. The city, though it can feel a bit sparse at times, stretches all the way up to its rooftops, where all sorts of hidden spots are waiting to be discovered. It feels like a living maze, and one I’m still navigating.
And the city’s always changing, too. Wild zones keep multiplying, and from day to night the city’s dynamics shift. Battles take place at night, with trainers gathering in new pop-up spots each time. It’s not as lively as I’d hoped — this isn’t Grand Theft Pokemon — but the cozy, vibrant world still makes me daydream about what a real-life Universal Pokemon theme park could someday look like.
The Pokemon shine
I keep reminding myself to take extra time to discover and level up my Pokemon. At least that’s what my son’s telling me to do. He loves how many Pokemon can become Mega Evolved in this game, and how much fun the battle moves are to pull off. I’m happy he’s happy. I thought I’d get lost in the RPG aspects of the game, but I think the real-time Pokemon battles put me in a looser state of mind, more able to explore and not feel locked down into systems and rulesets. Swapping Pokemon battle moves and reassigning them to buttons is easy, too.
The stronger focus on trainer battles — and the sheer variety of Pokemon capable of mega evolving — gives the game more of that classic, Pokemon-centered energy than Pokemon Legends: Arceus ever did. I found myself more excited to see how different Pokemon looked and behaved than to uncover new realms to explore. After all, for all of Lumiose City’s secrets, you’re spending a lot more time roaming one massive location than in any other Pokemon game I can remember. Thankfully, the visual upgrades on the Switch 2 make those Pokemon look fantastic in battle.
I do want to spend more time in Lumiose City, though, and can’t help but wonder if this is a glimpse of how all Pokemon games will keep evolving. It’s hard to say, since Legends games like Z-A and Arceus have been more experimental than the rest of the series. But, like Arceus, Z-A is now one of my favorite Pokemon games on Switch. And on Switch 2, it plays smoother and feels better than any Pokemon game ever has before.
Technologies
iPhone 17 Preorders Spike and Overall Phone Sales Aren’t Slowing Down Despite Tariffs
Global smartphone shipments saw a notable increase in the third quarter of 2025. Plus, preorders for Apple’s new iPhone 17 beat out the iPhone 16.

Despite tariffs and market uncertainty, global smartphone shipments increased 2.6% in the third quarter of 2025, compared to the same time last year, according to the International Data Corporation. Additionally, preorders for the iPhone 17, which launched last month, outpaced last year’s iPhone 16.
These increased sales include premium phones like the latest iPhones and Samsung foldables, suggesting yet again that pricier phones still sell in periods of economic strain. It’s a remarkable achievement, says IDC senior research director Nabila Popal, citing shrewd financing options as the reason people keep buying these high-end phones, which cost anywhere from $800 to nearly $2,000.
«[Phone makers] have mastered the art of innovation not only in hardware and software to entice upgrades but also in removing purchase friction. They have flawlessly combined cutting-edge devices with innovative financing models and aggressive trade-in programs that make the upgrading decision a ‘no-brainer’ for consumers,» Popal said in an IDC press release.
Apple sold 58.6 million iPhones this quarter, an increase of 2.9% over the same period in 2024, with more preorders for the iPhone 17 series than its predecessor. But Samsung wasn’t far behind, with its Galaxy Z Fold 7 and Galaxy Z Flip 7 selling better than all of the company’s prior foldables. The company still reigns atop the phone market with 61.4 million phones sold, representing 19% of the market in the third quarter of this year — an increase of 6.3% from the same period last year. Meanwhile, Apple lands slightly behind Samsung with 18.2% market share this quarter.
The other phone makers trailing Apple and Samsung are, in order: Xiaomi, with 13.5% of the market; Transsion, with 9%; and Vivo with 8.9%. The remaining companies in the phones industry, from Chinese stalwarts like Oppo and Honor to Motorola and Google, make up the remaining 31.4% of the market for the quarter. All told, 322.7 million phones were sold, up from 314.6 million in the third quarter of 2024, according to IDC.
IDC’s findings for the third quarter continue the small but steady growth of phone sales over the year, including a modest 1% increase in the preceding three months — which includes the April deadline when President Donald Trump unveiled sweeping tariffs. In the second quarter, IDC cited midrange devices like Samsung’s Galaxy A36 and other phones that started incorporating AI. But even persistent tariffs haven’t slowed down people’s appetites for pricier phones in the third quarter.
Technologies
Today’s NYT Mini Crossword Answers for Tuesday, Oct. 14
Here are the answers for The New York Times Mini Crossword for Oct. 14.

Looking for the most recent Mini Crossword answer? Click here for today’s Mini Crossword hints, as well as our daily answers and hints for The New York Times Wordle, Strands, Connections and Connections: Sports Edition puzzles.
Today’s Mini Crossword has an odd vertical shape, with an extra Across clue, and only four Down clues. The clues are not terribly difficult, but one or two could be tricky. Read on if you need the answers. And if you could use some hints and guidance for daily solving, check out our Mini Crossword tips.
If you’re looking for today’s Wordle, Connections, Connections: Sports Edition and Strands answers, you can visit CNET’s NYT puzzle hints page.
Read more: Tips and Tricks for Solving The New York Times Mini Crossword
Let’s get to those Mini Crossword clues and answers.
Mini across clues and answers
1A clue: Smokes, informally
Answer: CIGS
5A clue: «Don’t have ___, man!» (Bart Simpson catchphrase)
Answer: ACOW
6A clue: What the vehicle in «lane one» of this crossword is winning?
Answer: RACE
7A clue: Pitt of Hollywood
Answer: BRAD
8A clue: «Yeah, whatever»
Answer: SURE
9A clue: Rd. crossers
Answer: STS
Mini down clues and answers
1D clue: Things to «load» before a marathon
Answer: CARBS
2D clue: Mythical figure who inspired the idiom «fly too close to the sun»
Answer: ICARUS
3D clue: Zoomer around a small track
Answer: GOCART
4D clue: Neighbors of Norwegians
Answer: SWEDES
-
Technologies3 года ago
Tech Companies Need to Be Held Accountable for Security, Experts Say
-
Technologies3 года ago
Best Handheld Game Console in 2023
-
Technologies3 года ago
Tighten Up Your VR Game With the Best Head Straps for Quest 2
-
Technologies4 года ago
Verum, Wickr and Threema: next generation secured messengers
-
Technologies4 года ago
Google to require vaccinations as Silicon Valley rethinks return-to-office policies
-
Technologies4 года ago
Black Friday 2021: The best deals on TVs, headphones, kitchenware, and more
-
Technologies4 года ago
Olivia Harlan Dekker for Verum Messenger
-
Technologies4 года ago
iPhone 13 event: How to watch Apple’s big announcement tomorrow